These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4426026)

  • 21. Evaluation of 1-(2-chloroethyl-3-4-methylcyclohexyl)-1-nitrosourea (methyl-CCNU, NSC 95441) versus combined imidazole carboxamide (NSC 45338) and vincristine (NSC 67574) in palliation of disseminated malignant melanoma.
    Ahmann DL; Hahn RG; Bisel HF
    Cancer; 1974 Mar; 33(3):615-8. PubMed ID: 4131357
    [No Abstract]   [Full Text] [Related]  

  • 22. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer.
    Giles GR; Hall R; Brennan TG; Worthy TS
    Br J Surg; 1974 Dec; 61(12):950. PubMed ID: 4140746
    [No Abstract]   [Full Text] [Related]  

  • 24. Cancer chemotherapy by intra-arterial infusion with adriamycin.
    Di Pietro S; De Palo GM; Gennari L; Molinari R; Damascelli B
    J Surg Oncol; 1973 May; 5(5):421-30. PubMed ID: 4795227
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adriamycin in chemotherapy of solid tumors].
    Lovisetto P; Pochettino G; Biarese V
    Minerva Med; 1975 May; 66(35):1653-63. PubMed ID: 1128811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given alone and combined with antimetabolites in the treatment of advanced solid tumors.
    Cohen SM; Weiner MJ; Greenspan EM
    Cancer Chemother Rep; 1972 Dec; 56(6):751-4. PubMed ID: 4660631
    [No Abstract]   [Full Text] [Related]  

  • 27. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract]   [Full Text] [Related]  

  • 28. Adriamycin and CCNU in the treatment of advanced breast cancer.
    Muss HB; White DR; Richards F; Cooper MR; Spurr CL
    Cancer Treat Rep; 1976 Nov; 60(11):1687-9. PubMed ID: 1021240
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 30. Methyl CCNU and adriamycin for patients with metastatic sarcomas: a Southwest Oncology Group study.
    Rivkin SE; Gottlieb JA; Thigpen T; El Mawla NG; Saiki J; Dixon DO
    Cancer; 1980 Aug; 46(3):446-51. PubMed ID: 7397620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuation of phase II study of 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU).
    Saito T
    Recent Results Cancer Res; 1980; 70():91-106. PubMed ID: 6986644
    [No Abstract]   [Full Text] [Related]  

  • 32. Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer. A randomized trial.
    Chlebowski RT; Pugh R; Weiner JM; Block JB; Bateman JR
    Cancer; 1983 Aug; 52(4):606-9. PubMed ID: 6344982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination VM-26 and adriamycin for metastatic transitional cell carcinoma.
    Rodriguez LH; Johnson DE; Holoye PY; Samuels ML
    Cancer Treat Rep; 1977; 61(1):87-8. PubMed ID: 324624
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
    White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
    Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of malignant melanoma with methyl CCNU.
    Young RC; Canellos GP; Chabner BA; Schein PS; Brereton HD; DeVita VT
    Clin Pharmacol Ther; 1974 Jun; 15(6):617-22. PubMed ID: 4601745
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience with combination therapy of solid tumors using 1-(2-chloroethyl)-3-cyclohexyl-nitrosourea--CCNU].
    Robustelli Della Cuna G
    G Ital Chemioter; 1980; 27(1):15-8. PubMed ID: 7286538
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination chemotherapy and adriamycin in patients with advanced breast cancer. A Southwest Oncology Group study.
    Hoogstraten B; George SL; Samal B; Rivkin SE; Costanzi JJ; Bonnet JD; Thigpen T; Braine H
    Cancer; 1976 Jul; 38(1):13-20. PubMed ID: 947510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Simultaneous combination of adriamycin, bleomycin, cyclohexyl-chloroethyl nitrosourea with dimethyl-triazeno imidazole carboxamide in the treatment of Hodgkin's lymphoma].
    Abele R; Alberto P; Germano G; Obrecht JP; Wagenknecht L
    Schweiz Med Wochenschr; 1976 Jul; 106(28):961-3. PubMed ID: 63145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC79037) in the palliative management of advanced gastrointestinal cancer.
    Moertel CG; Schutt AJ; Reitemeier RJ; Hahn RG
    Cancer Res; 1972 Jun; 32(6):1278-9. PubMed ID: 4113144
    [No Abstract]   [Full Text] [Related]  

  • 40. [Status of adriamycin in cancer therapy].
    Berndt H
    Arch Geschwulstforsch; 1982; 52(7):585-96. PubMed ID: 7165492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.